Inflammatory bowel disease (IBD) exhibits paradoxical m6A regulatory dynamics: METTL3 and FTO demonstrate elevated expression concomitant with METTL14 and HuR downregulation (57). The gene discussed is METTL3; the disease is inflammatory bowel disease.